Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 25, 2022
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
Tue, May 24, 2022
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
Andrew Fein Maintained (UTHR) at Strong Buy with Increased Target to $255 on, May 24th, 2022
Andrew Fein of HC Wainwright & Co., Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Increased Target from $248 to $255 on, May 24th, 2022.
Andrew has made no other calls on UTHR in the last 4 months.
There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Julian Harrison of "BTIG" Initiated at Hold on, Friday, February 11th, 2022
This is the rating of the analyst that currently disagrees with Andrew
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Decreased Target to $203 on, Friday, February 25th, 2022
